亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Current Demography and Treatment Strategy of Vestibular Migraine in Neurotologic Perspective

偏头痛 前庭系统 透视图(图形) 医学 听力学 内科学 计算机科学 人工智能
作者
Kuei‐You Lin,Steven D. Rauch
出处
期刊:Otolaryngology-Head and Neck Surgery [Wiley]
卷期号:171 (6): 1842-1849 被引量:4
标识
DOI:10.1002/ohn.923
摘要

Abstract Objective This study aims to describe the demographic features of vestibular migraine (VM) compared to other common peripheral vestibulopathies, and to assess the efficacy of trigger management as primary VM treatment. Study Design Retrospective study. Setting Tertiary referral medical center. Methods A retrospective chart review was performed of patients presenting with dizziness in a tertiary neurotology clinic. Among the newly diagnosed dizzy patients, those with a diagnosis of either VM, Ménière's disease, benign paroxysmal positional vertigo, or vestibular neuritis/labyrinthitis were selected for comparisons of the disease demographics. VM patients with multiple clinic visits in the study period were included for the treatment strategy analysis. Results A total of 1285 patients met the study inclusion criteria. In the newly diagnosed dizzy group comprising 814 patients, VM patients accounted for the largest (25%) and youngest (mean age 47 years) cohort, showing an obvious female preponderance of approximately 3.3:1. Furthermore, prevalence of VM declined significantly with advancing age, from 69%, to 34%, to 11%, in age groups of ≤30, 31 to 60, and >60 years, respectively. Trigger management, when employed as the primary VM first‐year treatment, was effective for both sexes. Notably, it was more effective for women aged over than under 45 years. Conclusion In our tertiary referral neurotologic center, VM was the most common diagnosis in newly diagnosed dizzy patients aged under 60 years, especially in women. For primary VM treatment, trigger management is an effective option deserving consideration.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
7秒前
李健应助moral采纳,获得10
15秒前
小白发布了新的文献求助10
15秒前
25秒前
moral发布了新的文献求助10
29秒前
浩浩完成签到 ,获得积分10
59秒前
silence完成签到,获得积分10
1分钟前
miaomao完成签到,获得积分10
1分钟前
111完成签到,获得积分10
1分钟前
bruna应助poieu采纳,获得30
1分钟前
HYQ完成签到 ,获得积分10
2分钟前
披着羊皮的狼完成签到 ,获得积分0
3分钟前
英俊的铭应助miooo采纳,获得10
3分钟前
no1lbt完成签到,获得积分10
3分钟前
4分钟前
4分钟前
4分钟前
wangye发布了新的文献求助10
4分钟前
hugeyoung完成签到,获得积分10
4分钟前
Tt应助DAVID采纳,获得20
4分钟前
大个应助wangye采纳,获得10
4分钟前
4分钟前
GU完成签到,获得积分10
4分钟前
miooo发布了新的文献求助10
4分钟前
MchemG应助科研通管家采纳,获得10
5分钟前
BowieHuang应助科研通管家采纳,获得10
5分钟前
科研通AI2S应助科研通管家采纳,获得10
5分钟前
5分钟前
零玖完成签到 ,获得积分10
6分钟前
成就小蜜蜂完成签到 ,获得积分10
6分钟前
花花完成签到 ,获得积分10
6分钟前
6分钟前
ping发布了新的文献求助10
6分钟前
ping完成签到,获得积分10
6分钟前
7分钟前
MchemG应助科研通管家采纳,获得10
7分钟前
BowieHuang应助科研通管家采纳,获得10
7分钟前
李金奥完成签到 ,获得积分10
7分钟前
7分钟前
fanjianing发布了新的文献求助30
7分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Handbook on Climate Mobility 1111
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
Research Handbook on the Law of the Sea 1000
Contemporary Debates in Epistemology (3rd Edition) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6172176
求助须知:如何正确求助?哪些是违规求助? 7999608
关于积分的说明 16638604
捐赠科研通 5276311
什么是DOI,文献DOI怎么找? 2814271
邀请新用户注册赠送积分活动 1794031
关于科研通互助平台的介绍 1659771